Page last updated: 2024-10-23

bisindolylmaleimide i and Leukemia

bisindolylmaleimide i has been researched along with Leukemia in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Q1
Worland, PJ1
Clark, JL1
Carlson, BA1
Sausville, EA1

Other Studies

1 other study available for bisindolylmaleimide i and Leukemia

ArticleYear
Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1995, Volume: 6, Issue:8

    Topics: Alkaloids; Amino Acid Sequence; Apoptosis; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Division; C

1995